Anti-SPIN1 Antibody (A97209)

Name: Anti-SPIN1 Antibody
Brand: Antibodies.com
SKU: A97209
Price: 115.0 GBP
Availability: InStock

Enlarge Image

This product is discontinued

Anti-SPIN1 Antibody (A97209) has been discontinued and is no longer available.

View all SPIN1 Antibodies.

Specifications

Name

Anti-SPIN1 Antibody

Description

Rabbit polyclonal antibody to SPIN1.

Applications

WB, ELISA

Dilutions

WB: 1:500~1:1000, ELISA: 1:20000

Reactivity

Human, Mouse, Rat

Immunogen

Synthetic peptide derived from human SPIN1 (amino acids 111-160).

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugate

Unconjugated

Purification

Purified from rabbit serum by antigen affinity chromatography using the immunizing peptide.

Molecular Weight

29kDa

Product Form

Liquid

Formulation

Supplied in Phosphate Buffered Saline (without Mg2+ and Ca2+), pH 7.4, with 150mM NaCl, 0.02% Sodium Azide, and 50% Glycerol.

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Synonyms

OCR, Ovarian cancer-related protein, SPIN, Spindlin-1, Spindlin1

Isotype Controls

Suitable Secondaries

See all Anti-Rabbit IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (4)

Enlarge Image

Western Blot - Anti-SPIN1 Antibody (A97209)

Western blot analysis of lysates from HeLa cells using Anti-SPIN1 Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.

Enlarge Image

Western Blot - Anti-SPIN1 Antibody (A97209)

Western blot analysis of various cells using Anti-SPIN1 Antibody.

Enlarge Image

Western Blot - Anti-SPIN1 Antibody (A97209)

Western blot analysis of HeLa cells using Anti-SPIN1 Antibody.

Enlarge Image

Immunohistochemistry - Anti-SPIN1 Antibody (A97209)

Immunohistochemical analysis of paraffin-embedded human breast cancer using Anti-SPIN1 Antibody 1:100 (4°C overnight). The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.